A detailed history of Jpmorgan Chase & CO transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Jpmorgan Chase & CO holds 990 shares of XPH stock, worth $38,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares
990
Previous 9,123 89.15%
Holding current value
$38,897
Previous $379,000 88.92%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$41.38 - $45.49 $336,543 - $369,970
-8,133 Reduced 89.15%
990 $42,000
Q4 2023

Feb 12, 2024

BUY
$35.2 - $41.92 $309,196 - $368,225
8,784 Added 2591.15%
9,123 $379,000
Q2 2023

Aug 11, 2023

SELL
$39.1 - $42.57 $2,346 - $2,554
-60 Reduced 15.04%
339 $13,000
Q1 2023

May 11, 2023

BUY
$39.61 - $44.25 $2,376 - $2,655
60 Added 17.7%
399 $16,000
Q3 2022

Nov 14, 2022

SELL
N/A
-103,959 Reduced 99.67%
339 $14,000
Q2 2022

Aug 11, 2022

BUY
N/A
43,959 Added 72.85%
104,298 $4.38 Million
Q1 2022

May 11, 2022

BUY
N/A
32,581 Added 117.38%
60,339 $2.73 Million
Q4 2021

Feb 10, 2022

BUY
N/A
23,419 Added 539.73%
27,758 $1.28 Million
Q3 2021

Nov 12, 2021

BUY
N/A
4,339 New
4,339 $206,000

Others Institutions Holding XPH

About SPDR SER TR SPDR S&P PHARMACEU


  • Ticker XPH
  • Sector ETFs
  • Industry ETFs
More about XPH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.